Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Biological Chemistry|April 15, 1990
Interaction of heparin cofactor II with neutrophil elastase and cathepsin GC W Pratt, R B Tobin, F C ChurchThe Journal of Biological Chemistry|May 5, 1992
A comparison of three heparin-binding serine proteinase inhibitorsC W Pratt, H C Whinna, F C ChurchThe Journal of Biological Chemistry|April 25, 1985
Modification of histidines in human prothrombin. Effect on the interaction of fibrinogen with thrombin from diethyl pyrocarbonate-modified prothrombinF C Church, R L Lundblad, C M NoyesThe Journal of Biological Chemistry|June 25, 1991
Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptidesF C Church, J E Phillips, J L WoodsThe Journal of Biological Chemistry|January 10, 1997
Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor IIA V Ciaccia, A J Willemze, F C ChurchArchives of Biochemistry and Biophysics|April 1, 1988
In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitorsC W Pratt, F C Church, S V PizzoJournal of Protein Chemistry|November 20, 1997
Assessment of the interaction between urokinase and reactive site mutants of protein C inhibitorT P Jackson, S T Cooper, F C ChurchArchives of Biochemistry and Biophysics|April 1, 1986
Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structureF C Church, G B Villanueva, M J GriffithArchives of Biochemistry and Biophysics|July 2, 1998
Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitorL L Neese, C A Wolfe, F C ChurchThe Journal of Biological Chemistry|May 30, 1997
Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibitionA V Ciaccia, D M Monroe, F C ChurchPageof 8